CHOP

CHOP
Name	C/EBP homologous protein
Alt symbols	CHOP, GADD153
Organism	Homo sapiens
Uniprot	Q14141
Gene location	Chromosome 12p13.1
Length	169 aa
Function	Transcription factor involved in stress response and apoptosis

CHOP

CHOP is a stress-inducible transcription factor encoded by the DDIT3 gene that integrates signals from multiple cellular stressors to influence cell fate. First characterized in the context of DNA damage and growth arrest, CHOP is implicated in endoplasmic reticulum stress, oxidative injury, nutrient deprivation, and developmental programs in diverse tissues. Prominent research centers and consortia studying CHOP include laboratories affiliated with the National Institutes of Health, Harvard Medical School, Max Planck Society, University of California, San Francisco, and Stanford University.

Overview

CHOP belongs to the CCAAT/enhancer-binding protein (C/EBP) family and was originally identified through screens for genes induced by ionizing radiation and DNA damage responses. Its gene product is a 169-amino-acid basic-leucine zipper (bZIP) protein that heterodimerizes with other bZIP proteins such as C/EBPα, ATF4, and ATF3. CHOP lacks a canonical activation domain and often acts as a dominant-negative regulator of C/EBP-dependent transcription, modulating expression of target genes such as those encoding components of the unfolded protein response and apoptotic machinery. CHOP expression is evolutionarily conserved and has been studied in model organisms including Mus musculus, Danio rerio, and Drosophila melanogaster homologous pathways.

Structure and Function

The CHOP protein contains an N-terminal regulatory region and a C-terminal basic region-leucine zipper motif responsible for DNA binding and dimerization. Structural studies using techniques developed at institutions like European Molecular Biology Laboratory and Max Planck Institute indicate that CHOP forms heterodimers that bind DNA sequences overlapping C/EBP motifs and influence chromatin remodeling via interactions with cofactors such as HDAC1 and components of the SWI/SNF complex. Functional assays in cell lines derived from HeLa, HEK293, and primary mouse embryonic fibroblast cultures demonstrate CHOP’s ability to repress or activate transcription depending on partner proteins, post-translational modifications, and promoter context. Post-translational regulation includes phosphorylation sites targeted by kinases such as JNK1 and GSK3β, and ubiquitin-mediated turnover involving E3 ligases characterized in studies at Cold Spring Harbor Laboratory.

Biological Roles and Mechanisms

CHOP coordinates cellular responses to stress by regulating genes involved in protein folding, redox homeostasis, metabolism, and apoptosis. In the unfolded protein response (UPR), CHOP functions downstream of the PERK-eIF2α-ATF4 axis characterized in seminal work from Yale University and Walter and Ron laboratories; induction of CHOP contributes to expression of pro-apoptotic factors such as BIM and downregulation of chaperones like BiP/GRP78. CHOP also influences differentiation processes in tissues studied by groups at Johns Hopkins University and UCSF, including osteoblastogenesis and adipogenesis, via cross-talk with transcriptional regulators such as PPARγ and RUNX2. In neuronal models examined at Columbia University and MIT, CHOP mediates cell death after ischemia and excitotoxic insults through mitochondrial pathways involving BAX, BAK1, and cytochrome c release.

Regulation and Signaling Pathways

CHOP expression is induced by several signaling cascades: the PERK-eIF2α-ATF4 branch of the UPR; the IRE1-XBP1 pathway in coordination with stress-responsive transcription factors; the integrated stress response involving kinases like GCN2 and PKR; and pathways activated by oxidative stress sensors, hypoxia-inducible factors exemplified by HIF1A, and nutrient-sensing modules including mTORC1. Cytokine signaling from factors such as TNFα and growth factor withdrawal via receptors studied at Salk Institute can augment CHOP induction. Epigenetic control of the DDIT3 locus involves histone acetylation and methylation marks characterized in chromatin mapping initiatives at ENCODE and interactions with chromatin remodelers including BRG1.

Clinical Significance and Disease Associations

Aberrant CHOP activity is linked to a spectrum of human diseases. In metabolic disease, CHOP contributes to β-cell dysfunction and apoptosis in models of type 2 diabetes mellitus described in collaborations between University of Oxford and Imperial College London. In neurodegenerative disorders such as Alzheimer's disease and Parkinson's disease, CHOP-mediated neuronal loss is reported in studies from Massachusetts General Hospital and King's College London. CHOP also plays roles in cardiovascular pathology, including ischemia-reperfusion injury and atherosclerosis studied at Mayo Clinic and Cleveland Clinic. In oncology, chromosomal translocations involving DDIT3 produce fusion oncoproteins in myxoid liposarcoma, where partnerships with FUS or EWSR1 alter transcriptional programs; diagnostic and therapeutic approaches are under investigation at Memorial Sloan Kettering Cancer Center and Dana-Farber Cancer Institute. Genetic knockout and overexpression clinical correlations have been explored in population cohorts curated by UK Biobank and disease consortia.

Experimental Models and Research Methods

CHOP function is investigated using genetic knockout mice generated at facilities like Jackson Laboratory and conditional alleles produced with Cre-lox systems pioneered in laboratories at NIH. In vitro, ER stress is modeled using pharmacological agents such as tunicamycin and thapsigargin in cell systems including INS-1 β cells and primary hepatocytes. Transcriptomic profiling (RNA-seq) and chromatin immunoprecipitation followed by sequencing (ChIP-seq) performed at centers like Broad Institute map CHOP binding sites and downstream gene networks. Proteomic approaches employing mass spectrometry platforms at European Proteomics Centre identify CHOP interactomes, while CRISPR/Cas9 genome editing applied in core facilities at Stanford Genome Technology Center enables dissection of DDIT3 regulatory elements. Animal models of diabetes, neurodegeneration, and cancer continue to refine therapeutic strategies targeting CHOP-driven pathways.

Category:Transcription factors